de Zeeuw D - Search Results

1

Renal end points in clinical trials of kidney disease.

Weldegiorgis M, de Zeeuw D, Heerspink HJ. Weldegiorgis M, et al. Among authors: de zeeuw d. Curr Opin Nephrol Hypertens. 2015 May;24(3):284-9. doi: 10.1097/MNH.0000000000000118. Curr Opin Nephrol Hypertens. 2015. PMID: 25887898 Review.

2

Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability.

Kocks MJ, de Zeeuw D, Navis GJ. Kocks MJ, et al. Among authors: de zeeuw d. Curr Opin Nephrol Hypertens. 2002 Mar;11(2):135-40. doi: 10.1097/00041552-200203000-00002. Curr Opin Nephrol Hypertens. 2002. PMID: 11856904 Review.

3

Renal function as a predictor of prognosis in chronic heart failure.

Hillege H, Van Gilst W, de Zeeuw D, van Veldhuisen DJ. Hillege H, et al. Among authors: de zeeuw d. Heart Fail Monit. 2002;2(3):78-84. Heart Fail Monit. 2002. PMID: 12634888 Review.

4

Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.

Pinto-Sietsma SJ, Herrmann SM, Schmidt-Petersen K, Niu T, Hillege HL, Janssen WM, de Zeeuw D, de Jong P, Kreutz R. Pinto-Sietsma SJ, et al. Among authors: de jong p, de zeeuw d. J Am Soc Nephrol. 2003 Oct;14(10):2596-602. doi: 10.1097/01.asn.0000089827.03201.8e. J Am Soc Nephrol. 2003. PMID: 14514737

5

Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Verhave JC, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2004 May;15(5):1316-22. J Am Soc Nephrol. 2004. PMID: 15100372

6

Approaches and methods in gene therapy for kidney disease.

van der Wouden EA, Sandovici M, Henning RH, de Zeeuw D, Deelman LE. van der Wouden EA, et al. Among authors: de zeeuw d. J Pharmacol Toxicol Methods. 2004 Jul-Aug;50(1):13-24. doi: 10.1016/j.vascn.2004.03.004. J Pharmacol Toxicol Methods. 2004. PMID: 15233963 Review.

7

Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.

Ochodnicky P, Vettoretti S, Henning RH, Buikema H, Van Dokkum RP, de Zeeuw D. Ochodnicky P, et al. Among authors: de zeeuw d. J Nephrol. 2006 May-Jun;19(3):246-58. J Nephrol. 2006. PMID: 16874683 Review.

8

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.

Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT. Halbesma N, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2006 Sep;17(9):2582-90. doi: 10.1681/ASN.2005121352. Epub 2006 Aug 9. J Am Soc Nephrol. 2006. PMID: 16899519

9

The role of angiotensin(1-7) in renal vasculature of the rat.

van der Wouden EA, Ochodnický P, van Dokkum RP, Roks AJ, Deelman LE, de Zeeuw D, Henning RH. van der Wouden EA, et al. Among authors: de zeeuw d. J Hypertens. 2006 Oct;24(10):1971-8. doi: 10.1097/01.hjh.0000244945.42169.c0. J Hypertens. 2006. PMID: 16957556

10

Update on microalbuminuria as a biomarker in renal and cardiovascular disease.

Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de Zeeuw D. Lambers Heerspink HJ, et al. Among authors: de zeeuw d. Curr Opin Nephrol Hypertens. 2006 Nov;15(6):631-6. doi: 10.1097/01.mnh.0000247496.54882.3f. Curr Opin Nephrol Hypertens. 2006. PMID: 17053479 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

655 results

Search Page